This inventor holds 1 USPTO granted patent. Top assignee: Diacrin, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovative Mind of Thomas Fraser
Introduction
Thomas Fraser, an inventive mind based in Newton, MA, holds a significant patent in the field of neuroscience. His groundbreaking work explores the application of porcine neural cells in treating neurological deficits resulting from various neurodegenerative diseases. With a dedication to advancing medical research, Fraser's innovation showcases the potential of utilizing animal cells for human therapeutic benefits.
Latest Patents
Fraser’s patent focuses on "Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases." This patent entails a novel method of using porcine neural cells, specifically embryonic mesencephalic, striatal, or cortical cells, to address conditions such as epilepsy, head trauma, stroke, and other neurological disorders. The cells can be modified to reduce immune rejection when transplanted into human subjects, increasing their viability and effectiveness in treatment.
Career Highlights
Fraser works with Diacrin, Inc., a company dedicated to advancing scientific understanding and treatment of neurological disorders. His involvement in this innovative space underscores his commitment to enhancing therapies for patients suffering from life-altering conditions. With only one patent, Fraser has already made a lasting impact on the field of neuroregeneration.
Collaborations
Throughout his career, Fraser has collaborated with notable colleagues, including Jonathan H Dinsmore. Together, they have contributed to research that pushes the boundaries of current medical treatments, fostering advancements in therapeutic strategies for complex neurological challenges.
Conclusion
In summary, Thomas Fraser exemplifies the spirit of innovation in neuroscience. His patent on porcine neural cells not only highlights his original thinking but also represents a significant step toward effective treatments for debilitating neurological conditions. As he continues his work at Diacrin, Inc., Fraser remains a pivotal figure in the ongoing quest for improved health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile